Cellular platforms for HTS: three case studies
PA Johnston, PA Johnston - Drug discovery today, 2002 - Elsevier
The field of cell-based screening is expanding rapidly as innovations in target selection and
instrumentation increase the number of targets that can be efficiently screened in cellular …
instrumentation increase the number of targets that can be efficiently screened in cellular …
Scintillation proximity assays in high-throughput screening
JF Glickman, A Schmid, S Ferrand - Assay and drug development …, 2008 - liebertpub.com
Scintillation proximity assays (SPAs) have become a powerful tool for high-throughput
screening (HTS) because they can measure the activity and binding of very diverse classes …
screening (HTS) because they can measure the activity and binding of very diverse classes …
Requirement for cellular cyclin-dependent kinases in herpes simplex virus replication and transcription
LM Schang, J Phillips, PA Schaffer - Journal of virology, 1998 - Am Soc Microbiol
Several observations indicate that late-G1/S-phase-specific cellular functions may be
required for herpes simplex virus (HSV) replication:(i) certain mutant HSV strains are …
required for herpes simplex virus (HSV) replication:(i) certain mutant HSV strains are …
Biochemical and cellular effects of c-Src kinase-selective pyrido [2, 3-d] pyrimidine tyrosine kinase inhibitors
AJ Kraker, BG Hartl, AM Amar, MR Barvian… - Biochemical …, 2000 - Elsevier
Increased expression or activity of c-Src tyrosine kinase has been associated with the
transformed phenotype in tumor cells and with progression of neoplastic disease. A number …
transformed phenotype in tumor cells and with progression of neoplastic disease. A number …
Pharmacological characterization of human excitatory amino acid transporters EAAT1, EAAT2 and EAAT3 in a fluorescence-based membrane potential assay
AA Jensen, H Bräuner-Osborne - Biochemical pharmacology, 2004 - Elsevier
We have expressed the human excitatory amino acid transporters EAAT1, EAAT2 and
EAAT3 stably in HEK293 cells and characterized the transporters pharmacologically in a …
EAAT3 stably in HEK293 cells and characterized the transporters pharmacologically in a …
Ex Vivo Activity of Cardiac Glycosides in Acute Leukaemia
H Hallböök, J Felth, A Eriksson, M Fryknäs, L Bohlin… - PloS one, 2011 - journals.plos.org
Background Despite years of interest in the anti-cancerous effects of cardiac glycosides
(CGs), and numerous studies in vitro and in animals, it has not yet been possible to utilize …
(CGs), and numerous studies in vitro and in animals, it has not yet been possible to utilize …
Temporal effects of the novel antitumour pyridyl cyanoguanidine (CHS 828) on human lymphoma cells
P Martinsson, G Liminga, S Dhar, M De la Torre… - European Journal of …, 2001 - Elsevier
CHS 828, a novel pyridyl cyanoguanidine, has shown potent antitumour activity both in vitro
and in vivo and is currently undergoing phase I evaluation in humans in collaboration with …
and in vivo and is currently undergoing phase I evaluation in humans in collaboration with …
Antitumor activity of the alkylating oligopeptides J1 (L-melphalanyl-pL-fluorophenylalanine ethyl ester) and P2 (L-prolyl-mL-sarcolysyl-pL-fluorophenylalanine ethyl …
J Gullbo, S Dhar, K Luthman, H Ehrsson… - Anti-cancer …, 2003 - journals.lww.com
Peptichemio, a mixture of six short oligopeptides all comprising the alkylating amino acid mL-
sarcolysin, has shown clinical activity in several malignancies. Previous studies have …
sarcolysin, has shown clinical activity in several malignancies. Previous studies have …
Efficacy of repeated intrathecal triamcinolone acetonide application in progressive multiple sclerosis patients with spinal symptoms
Background There are controversial results on the efficacy of the abandoned, intrathecal
predominant methylprednisolone application in multiple sclerosis (MS) in contrast to the …
predominant methylprednisolone application in multiple sclerosis (MS) in contrast to the …
Early stimulation of acidification rate by novel cytotoxic pyridyl cyanoguanidines in human tumor cells: comparison with m-iodobenzylguanidine
S Ekelund, G Liminga, F Björkling, E Ottosen… - Biochemical …, 2000 - Elsevier
CHS 828, a newly recognized pyridyl cyanoguanidine, has shown promising antitumor
activity both in vitro and in vivo and is presently in early phase I clinical trial in collaboration …
activity both in vitro and in vivo and is presently in early phase I clinical trial in collaboration …